A case of ibrutinib-associated aspergillosis presenting with central nervous system, myocardial, pulmonary, intramuscular, and subcutaneous abscesses

Leuk Lymphoma. 2019 Feb;60(2):559-561. doi: 10.1080/10428194.2018.1494271. Epub 2018 Aug 2.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Abscess / diagnosis*
  • Abscess / drug therapy
  • Abscess / etiology*
  • Adenine / analogs & derivatives
  • Antifungal Agents / therapeutic use
  • Aspergillosis / diagnosis*
  • Aspergillosis / drug therapy
  • Aspergillosis / etiology*
  • Humans
  • Leukemia, B-Cell / complications
  • Leukemia, B-Cell / diagnosis
  • Lymphoma, B-Cell / complications
  • Lymphoma, B-Cell / diagnosis
  • Organ Specificity
  • Piperidines
  • Protein Kinase Inhibitors / adverse effects*
  • Protein Kinase Inhibitors / therapeutic use
  • Pyrazoles / adverse effects*
  • Pyrazoles / therapeutic use
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Piperidines
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyrimidines
  • ibrutinib
  • Adenine